Rhythm Pharmaceuticals buy UBS Group AG
Start price
17.12.25
/
50%
€95.50
Target price
17.12.26
-
Performance (%)
-9.42%
Price
09.01.26
€82.50
Summary
This prediction is currently active. With a performance of -9.42%, the BUY prediction by UBS_Group_AG is trending in the wrong direction. This prediction currently runs until 17.12.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Rhythm Pharmaceuticals | -7.303% |
| iShares Core DAX® | 3.002% |
| iShares Nasdaq 100 | 2.966% |
| iShares Nikkei 225® | 5.606% |
| iShares S&P 500 | 2.312% |
Comments by UBS_Group_AG for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (NASDAQ:RYTM) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for RYTM provided by MarketBeat